This site is for U.S. residents only.
Call to talk to a registered nurse
(1-855-767-5283) Monday–Friday, 9:00am-9:00pm et
Pregnancy Surveillance Program: Women who become pregnant during Nplate® treatment are encouraged to enroll in Amgen’s Pregnancy Surveillance Program. The purpose of this program is to collect safety information about the health of you and your baby. Contact the program as soon as you become aware of the pregnancy, or ask your healthcare provider to contact the program for you. You or your healthcare provider can get information and enroll in the program by calling 1-800-77-AMGEN (1-800-772-6436)1-800-77-AMGEN (1-800-772-6436).
Please see Prescribing Information and Medication Guide for more information about Nplate® on Nplate.com.
Nplate® is a man-made protein medicine used to treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP), when certain other medicines, or surgery to remove your spleen, have not worked well enough.
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndrome (MDS) or low platelet count caused by any condition other than chronic (lasting a long time) immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 18.
The product information provided in this site is intended only for residents of the United States.
The products discussed herein may have different product labeling in different countries.
Nplate® is a registered trademark of Amgen, Inc.
©2018 Amgen Inc. All rights reserved.